Impaired insulin action despite upregulation of proximal insulin signaling: Novel insights into skeletal muscle insulin resistance in liver cirrhosis

Journal of Hepatology

Volumn 45, Issue 6, 2006, Pages 797-804

  Jessen, Niels ^a   Buhl, Esben Selmer ^a,b   Schmitz, Ole ^a,b   Lund, Sten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Animal model; Insulin sensitivity; Insulin signaling; Liver cirrhosis

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; LIVER ENZYME; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HISTOLOGY; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; INSULIN; INSULIN RESISTANCE; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR;

EID: 33750478658     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.07.035     Document Type: Article

References (42)

1. Megyesi C., Samols E., and Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 2 (1967) 1051-1056
2. Johnston D.G., Alberti G.M., Wright R., Smith-Laing G., Stewart A.M., Sherlock S., et al. C-peptide and insulin in liver disease. Diabetes 27 Suppl. 1 (1978) 201-206
3. Leatherdale B.A., Chase R.A., Rogers J., Alberti K.G., Davies P., and Record C.O. Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance. Clin Sci 59 (1980) 191-198
4. Selberg O., Burchert W., Hoff J., Meyer G.J., Hundeshagen H., Radoch E., et al. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 91 (1993) 1897-1902
5. Petersen K.F., Krssak M., Navarro V., Chandramouli V., Hundal R., Schumann W.C., et al. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. Am J Physiol 276 (1999) E529-E535
6. Petrides A.S., Stanley T., Matthews D.E., Vogt C., Bush A.J., and Lambeth H. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology 28 (1998) 141-149
7. Zierath J.R., and Wallberg-Henriksson H. From receptor to effector: insulin signal transduction in skeletal muscle from type II diabetic patients. Ann NY Acad Sci 967 (2002) 120-134
8. Lund S., Holman G.D., Schmitz O., and Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92 (1995) 5817-5821
9. Yeh J.I., Gulve E.A., Rameh L., and Birnbaum M.J. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270 (1995) 2107-2111
10. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., and Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14 (1994) 4902-4911
11. Alessi D.R., and Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 8 (1998) 55-62
12. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 106 (2000) 171-176
13. Kountouras J., Billing B.H., and Scheuer P.J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65 (1984) 305-311
14. Henriksen E.J., and Holloszy J.O. Effect of diffusion distance on measurement of rat skeletal muscle glucose transport in vitro. Acta Physiol Scand 143 (1991) 381-386
15. Lund S., Holman G.D., Schmitz O., and Pedersen O. Glut 4 content in the plasma membrane of rat skeletal muscle: comparative studies of the subcellular fractionation method and the exofacial photolabelling technique using ATB-BMPA. FEBS Lett 330 (1993) 312-318
16. Wallberg-Henriksson H., Zetan N., and Henriksson J. Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. Insulin is not required. J Biol Chem 262 (1987) 7665-7671
17. Wojtaszewski J.F., Hansen B.F., Urso B., and Richter E.A. Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle. J Appl Physiol 81 (1996) 1501-1509
18. Jessen N., Pold R., Buhl E.S., Jensen L.S., Schmitz O., and Lund S. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 94 (2003) 1373-1379
19. Buhl E.S., Jessen N., Schmitz O., Pedersen S.B., Pedersen O., Holman G.D., et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50 (2001) 12-17
20. Lund S., Flyvbjerg A., Holman G.D., Larsen F.S., Pedersen O., and Schmitz O. Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol 267 (1994) E461-E466
21. Kahn C.R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27 (1978) 1893-1902
22. Bjornholm M., Kawano Y., Lehtihet M., and Zierath J.R. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46 (1997) 524-527
23. Goodyear L.J., Giorgino F., Sherman L.A., Carey J., Smith R.J., and Dohm G.L. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95 (1995) 2195-2204
24. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277 (2002) 50230-50236
25. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., and White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277 (2002) 1531-1537
26. Krook A., Roth R.A., Jiang X.J., Zierath J.R., and Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47 (1998) 1281-1286
27. Zisman A., Peroni O.D., Abel E.D., Michael M.D., Mauvais-Jarvis F., Lowell B.B., et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6 (2000) 924-928
28. Andersen P.H., Lund S., Vestergaard H., Junker S., Kahn B.B., and Pedersen O. Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab 77 (1993) 27-32
29. Lin S.Y., Sheu W.H., Chen W.Y., Lee F.Y., and Huang C.J. Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha. Mol Cell Endocrinol 232 (2005) 1-8
30. Plomgaard P., Bouzakri K., Krogh-Madsen R., Mittendorfer B., Zierath J.R., and Pedersen B.K. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54 (2005) 2939-2945
31. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
32. Steppan C.M., Wang J., Whiteman E.L., Birnbaum M.J., and Lazar M.A. Activation of SOCS-3 by resistin. Mol Cell Biol 25 (2005) 1569-1575
33. Ji H., Jiang J.Y., Xu Z., Kroeger E.A., Lee S.S., Liu H., et al. Change in lipid profile and impairment of endothelium-dependent relaxation of blood vessels in rats after bile duct ligation. Life Sci 73 (2003) 1253-1263
34. Lillioja S., Young A.A., Culter C.L., Ivy J.L., Abbott W.G., Zawadzki J.K., et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80 (1987) 415-424
35. Armstrong R.B., and Phelps R.O. Muscle fiber type composition of the rat hindlimb. Am J Anat 171 (1984) 259-272
36. Muller M.J., Willmann O., Rieger A., Fenk A., Selberg O., Lautz H.U., et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 102 (1992) 2033-2041
37. Petrides A.S., Groop L.C., Riely C.A., and DeFronzo R.A. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J Clin Invest 88 (1991) 561-570
38. Shulman G.I., Rothman D.L., Jue T., Stein P., DeFronzo R.A., and Shulman R.G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322 (1990) 223-228
39. Cline G.W., Petersen K.F., Krssak M., Shen J., Hundal R.S., Trajanoski Z., et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341 (1999) 240-246
40. Selberg O., Radoch E., Walter G.F., and Muller M.J. Skeletal muscle glycogen content in patients with cirrhosis. Hepatology 20 (1994) 135-141
41. Johansson U., Eriksson L.S., Galuska D., Zierath J.R., and Wallberg-Henriksson H. Insulin action on glucose transport in isolated skeletal muscle from patients with liver cirrhosis. Scand J Gastroenterol 29 (1994) 71-76
42. Tomaszewski K.E., Harries G.C., and Jeffrey P. The production of hepatic cirrhosis in rats. J Appl Toxicol 11 (1991) 229-231